 "Themis Medicare hits record high on strong Q2 results")
Themis Medicare has locked in upper circuit for seven straight trading days, up 5% at Rs 376, also its record high on the BSE, after the company reported a consolidated net profit at Rs 6.59 crore for the quarter ended September 2015 (Q2).
The pharmaceutical company had net loss of Rs 58 lakh in the same quarter year ago.
Net sales of the company during the quarter increased by 49% at Rs 63.13 crore against Rs 42.80 crore in the corresponding quarter of previous fiscal.
The company said change in sales mix coupled with reduction in finance cost has resulted in improved bottom line working for the half year on consolidated basis with profit before tax of Rs 12.42 crore against Rs 3.19 crore.
Post Q2 results, the stock zoomed 40% from Rs 268 on November 4, 2015 compared to 3% decline in S&P BSE Sensex.
Till 02:00 PM, a combined 43,111 shares changed hands and there were pending buy orders for 26,347 shares on the BSE and NSE.
The pharmaceutical company had net loss of Rs 58 lakh in the same quarter year ago.
Net sales of the company during the quarter increased by 49% at Rs 63.13 crore against Rs 42.80 crore in the corresponding quarter of previous fiscal.
The company said change in sales mix coupled with reduction in finance cost has resulted in improved bottom line working for the half year on consolidated basis with profit before tax of Rs 12.42 crore against Rs 3.19 crore.
Post Q2 results, the stock zoomed 40% from Rs 268 on November 4, 2015 compared to 3% decline in S&P BSE Sensex.
Till 02:00 PM, a combined 43,111 shares changed hands and there were pending buy orders for 26,347 shares on the BSE and NSE.
